HS rxns, transplant, cell migration (Ben) Flashcards

1
Q

Examples of Type III HS rxns

A

Ab-Ag complex mediated…

  • SLE - anti-RNP and anti-cardiolipin Abs
  • Rheumatoid Arthritis - rheumatoid factor Ab
  • Serum Sickness - Abs against anti-venom, etc.
  • Penicillin Allergy - binds to RBCs –> Ab binding
  • Arthus Reaction - local reaction to injected proteins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Examples of Type II HS rxns

A

IgG against cell surface/matrix antigens…

Cytotoxic:

  • Rh incompatibility: erythroblastosis fetalis
  • Drug hypersensitivity: ex: penicillin –> RBC –> IgG

Non-cytotoxic:

  • Graves/Basedow: TSH-R Ab stimulates T3/T4 release
  • Myasthenia Gravis: anti-nAChR Ab
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Examples of Type IV HS rxns…

A

2-3 day delayed, T-cell mediated

  • Contact Dermatitis: poison ivy complexes with skin proteins –> APCs activate T cells –> memory Ts react to poison ivy/skin complex quickly next time (also via Ni)
  • Multiple Sclerosis: T cells against myelin basic protein
  • Hashimoto’s: hypothyroidism, unknown thyroid Ag
  • Type I DM
  • Celiac: rxn against de-amidated gliadin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

5 results of complement activation

A
  1. Lysis - via MAC formation
  2. Opsonization - C4b/3b -> CR1-mediated phagocytosis
  3. Inflammation - C3a/4a/5a anaphylatoxins
  4. B cell activation - C3d binds CR2 on B cells
  5. Immune Complex Clearance - RBCs carry C3b bound complexes to spleen/liver macrophages via CR1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

4 reasons ABO antibodies are produced under normal conditions

A
  1. Previous contact with foreign blood
  2. Maternal antigen exposure
  3. Carbohydrate antigens of intestinal microbes
  4. Exposure via plant pollens
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe “hyperacute rejection” of an allogenic graft.

(timescale, mechanism)

A
  • takes minutes - hours
  • usually occurs via ABO, HLA or VEC (vascular endothelial cell antigen) incompatibility
  • ex: endothelial cells express “allo-antigens” which are bound by host antibodies leading to complement activation, inflammation, endothelial damage + thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What kind of cells are involved in host vs. graft rejection?

A
  • T cells (both CD4 + CD8)
  • NK cells
  • Macrophages
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Describe acute rejection against an allogenic graft.

(timescale, mechanism)

A
  • occurs up to 1 month after graft procedure
  • involves endothelitis in which IgG binds alloantigens on endothelium
  • delayed-type (IV) hypersensitivity occurs via CD4+ Th1, CD8+ cells + macrophages
  • causes intense parenchymal damage + interstitial inflammation
  • (no complement activation)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe chronic rejection of an allogenic graft.

(timeframe, mechanism)

A
  • occurs months to years after the graft procedure
  • causes fibrosis and vascular sclerosis
  • due to a chronic type IV HS rxn, intimal SM cell proliferation will lead to vessel occlusion
  • (alloantigen-specific CD4+ cells release cytokines which cause SM prolif.)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Describe the general procedure of a bone marrow graft.

A
  1. Donor (usually family) gives marrow cells via pelvic marrow harvest procedure.
  2. Recipient is treated with radiation and/or chemotherapy to achieve “cytoablation” (removal of their own cancerous marrow cells; also prevents HVG disease)
  3. Marrow transplant is applied to recipient intravenously + the transplanted hematopoietic stem cells repopulate the marrow.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is apheresis?

How is it used in bone marrow transplantation?

A
  • removal of a certain component of the blood + return of the remaining components to circulation
  • can be used to remove HSCs from donor’s peripheral blood, rather than via painful pelvic marrow harvest
  • (2-3% peripherally circulating WBCs are stem cells)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Name 3 molecules involved in the damage caused by Graft vs. Host Disease

A

All are CD8+ cell products…

  1. TNF
  2. FasL - binds FasR to induce apoptosis
  3. Perforin-Granzyme system - perforin makes hole in membrane + granzymes enter to induce apoptosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

List the target cells + organs of acute GVHD

A
  • mostly endothelial cells are damaged
  • main target organs are skin, liver, GI
  • (VEC (vascular endothelial cell) antigens are highly immunogenic –> when these cells are damaged + their antigens released, further damage occurs in surrounding tissues)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What pathological changes are seen in chronic GVHD?

A
  • fibrosis and atrophy of tissues leading to loss of function
  • externally, skin color changes appear, showing up as spots on the skin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

What are 2 biological rejection suppression techniques?

A
  1. Donor Selection - genotyping for immunological compatibility (family / internatn’l tranplant lists)
  2. Ex Vivo Graft Manipulation - suppression of immune cells in graft
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are 3 kinds of ex vivo graft manipulation?

A
  1. Steroid Infusion - graft is infused with corticosteroids to downregulate MHC expression
  2. Tolerance Induction - (no details on this…)
  3. Antibodies - e.g. anti-CD28, anti-MHCII, anti-CD4
17
Q

How does cyclosporin work as a pharmaceutical rejection suppression agent?

(What other drug works this way?)

A
  • blocks NFAT, a transcription factor for IL-2 (thus downregulation T cell proliferation)
  • (FK506 also works this way)
18
Q

How do azathioprineandcyclophosphoamide work in pharmacological rejection suppression?

A
  • both block lymphocyte proliferation
  • (azathioprine via purine synthesis inhibition; cyclophosphamide mechanism is… less clear)
19
Q

Other than the drugs already mentioned…

what are 3 methods for pharmaceutical suppression of graft rejection?

A
  1. Monoclonal Abs - most aimed at T-cell depletion, such as anti-CD3 mAb
  2. Corticosteroids - such as prednisone
  3. Other anti-inflammatory agents
20
Q

What are some (6) immunological changes seen in pregnancy?

(too much for one card… just an overview)

A
  1. Th2 shift
  2. HLA-G - a non-classical HLA expressed on fetal-derived placenta cells
  3. Blocking antibodies - bind antigens without inducing immune response, block other Abs from binding
  4. Decrease of CD8+ cells
  5. hCG and IL-6 release from placenta + female GU tract
  6. PIBF - leads to incr. IL-10 and decr. NK cells
21
Q

What role do trophoblast cells play in the fetal antigen presentation + gestational immune tolerance?

A
  • have no MHC-II
  • have monomorphic MHC-I-like HLA-G/E molecules which:
    • don’t present to CD8+ cells
    • block NK cells (normally activated by MHC-I absence)
22
Q

What cytokines + cell types (2) are important in immunosuppression during pregnancy?

A
  • Th2 cytokines - block Th1 type rxns against fetus
  • TGF-beta - multiple suppressive effects
  • Treg - CD4+/CD25+ cells
  • gamma-delta-T cells
23
Q

What important transcription factor is expressed by Treg cells in the decidua during pregnancy?

24
Q

When during pregnancy are Treg levels highest?

(this is probably not necessary, just showed up on a graph in lecture, but wasnt mentioned)

A

Treg levels rise slowly to a peak around week 10-11 and then decline slowly again until birth

25
how are pregnancy-related Tregs created? from what kind of cells? what general role do they play? (also not super important... just seen in a lecture figure)
* naive **CD4+ cells** become Tregs * presentation of **paternal alloantigens** to CD4+ induces differentiation into "**pTreg**" cells (p=pregnancy?) * pTregs ensure embryo/fetal tolerance and vascularization
26
Aside from pTregs, what other kind of cell is important in gestational immune tolerance? Name 4 mechanisms by which they promote tolerance (less important than just the cell type, also from a lecture figure)
**gamma delta T cells** - leave thymus without CD4 or CD8 + present in placental mucosa * suppression + cytolysis of effector Ts * secrete Th1 antagonizing cytokines * cytolysis of APCs * block neutrophil infiltration
27
What three sources provide immunosuppresive _hormones_ during pregnancy? What are the hormones?
1. Maternal - **progesterone + estrogen** 2. Placental - **hCG** 3. Fetal - **alpha-1-fetoprotein**
28
What important molecule is stimulated by a _maternal hormone_ during pregnancy and contributes to numerous mechanisms for gestational immunosuppression? What mechanisms (5)?
**PIBF** - progesterone-induced blocking factor * inhibits NK cells * increases Th2 cytokines * has "anti-abortive" effects * inhibits arachidonic acid metabolism * increases _asymmetric Ab_ synthesis
29
What are **assymetric antibodie**s?
Abs that have an extra glycosylation in the Fab region, causing them to be "blocking antibodies" which bind antigen but do not activate effector mechanisms
30
What is the difference between chemotaxis and chemokinesis?
* Chemotaxis is _vectorial_ meaning it has a specific direction * Chemokinesis is _random_, without specific direction
31
What is **haptotaxis**?
* chemotaxis in which the attractant is _bound to a surface_ such as the extracellular matrix * ex: axonal outgrowth based on the conc. gradient of adhesion sites
32
What are 4 kinds of "professional" chemoattractants?
* **chemokines** (CC and CXC family) * **C3a** and **C5a** ("anaphylatoxins") * **bacterial N-formyl peptides** (FP) * **arachidonic acid products**
33
What are the 4 classes of chemokines + an example of each? (examples not that important, except one)
* **CC** - "RANTES"/CCL5 - eos-/baso-/T cell attractant * **CXC** - CXCL8/**IL-8** - mostly from macrophages to attract neutrophils * **CX3CL** - "fractalkine" * **C** - "lymphotactine" - attracts T cells
34
Describe the **3 chamber technique** for evaluation of chemotactic agents.
* agarose plate with 3 sets of wells * in one set, place attractant; in another place cells; in third place neutral control substance * measure the "diameter" of the movement of the cells toward the attractant (dA) and control (dC) * dA \> dC if tested substances is true chemoattractant
35
Describe the **2 chamber method** for evaluating chemoattractant strength.
* one chamber = cells * other chamber = chemoattractant * between them = semi-permeable membrane * after some time, can count # of cell that migrated across membrane to chemoattractant
36
In assays of _transendothelial migration_ ... what is the difference between _direct_ and _reverse_ TEM assays?
* **direct** - migrating cells placed directly on endothelial cell layer, with filters btwn endoth. + chemoattractant * **reverse** - cells placed directly on filters with endothelial cells below (measures what conc. of chemoattractant needed to "pull" cells thru filter to endothelium)
37
How are migration assays performed on the wall of a cell culture flask?
* coat one side of the flask with **ECM peptides** * load cells onto bottom of flask + let them adhere (24 h) * tilt flask and wait 1-10 days as cells culture + migrate * can measure migration of cells along ECM peptide layer
38
Describe the "**matrigel**" technique for in vivo cell migration measurement.
* a gel disk containing chemoattractant (+ sandwiched btwn a thick and thin filter) is inserted into a test animal subcutaneously * wait 5-10 days to allow cell migration to occur * remove disk, wash with NaCl, fixate + evaluate amt of cells which have migrated into it
39
How can **sephadex beads** be used to measure in vivo cell migration?
* inject chemoattractant-infused beads into test animal peritoneal cavity * wait 6-48 hrs * observe granulocyte/monocyte migration into peritoneal cavity + presence of cytokines (LTB4, TNF-a, IL8)